Manufacturing challenges in regenerative medicine

Sci Transl Med. 2014 Apr 16;6(232):232fs16. doi: 10.1126/scitranslmed.3008558.


Along with scientific and regulatory issues, the translation of cell and tissue therapies in the routine clinical practice needs to address standardization and cost-effectiveness through the definition of suitable manufacturing paradigms.

MeSH terms

  • Cell- and Tissue-Based Therapy / methods*
  • Humans
  • Regenerative Medicine / methods*
  • Tissue Engineering / methods*